Global Pharmaceutical Dissolution Testing Market Size, Share & Trends Analysis Report By Dosage Form , By Dissolution Apparatus, By End User, By Region, And Segment Forecasts, 2024 - 2031
- Published Date : 2024-09-20
- Pages : 100
- Report Id : 40467
- Categories : Healthcare
This report describes the global market size of Pharmaceutical Dissolution Testing from 2019 to 2022 and its CAGR from 2019 to 2023, and also forecasts its market size to the end of 2031 and its expected to grow with a CAGR of 30.5% from 2024 to 2031.
Due to the COVID-19 pandemic and Russia-Ukraine War Influence, the global market for Pharmaceutical Dissolution Testing estimated at US $6.25Billion in the year 2022, is projected to reach a revised size of US $ 1,374.15 Billion by 2031, growing at a CAGR of 30.5% during the forecast period 2024-2031.
Pharmaceutical dissolution testing is a laboratory process used to measure the rate and extent at which a drug is released from its dosage form (e.g., tablet or capsule) and dissolved in a liquid medium, typically mimicking bodily fluids. This test is crucial in evaluating the bioavailability of a drug, ensuring that it releases its active ingredients at the appropriate rate to achieve therapeutic effects. Dissolution testing helps pharmaceutical companies assess the consistency of drug batches, optimize formulations, and meet regulatory standards. It also plays a significant role in drug development, stability testing, and quality control. By simulating in vivo conditions, dissolution testing provides insight into how a drug will behave in the human body, making it a critical tool for ensuring the safety and efficacy of medications.
For geography segment, regional supply, demand, major players, price is presented from 2019 to 2031. This report cover following regions:
North America
Asia-Pacific
Europe
Middle East and Africa
South America
The key countries for each regions are also included such as United States, China, Japan, India, Korea, ASEAN, Germany, France, UK, Italy, Spain, CIS, and Brazil etc.
For competitor segment, the report include global key players of Pharmaceutical Dissolution Testing as well as some small players. The information for each competitor include:
Company Profile
Main Business Information
SWOT Analysis
Sales Volume, Revenue, Price and Gross Margin
Market Share
By Dosage Form
Capsules
Tablets
Others
In pharmaceutical dissolution testing, different dosage forms require tailored approaches to ensure accurate assessment of drug release. Capsules are a common dosage form, often containing powders, liquids, or granules encased in a gelatin shell, and dissolution testing evaluates how quickly the shell dissolves and releases the active ingredients. Tablets, being solid, compressed forms, require dissolution testing to ensure the tablet breaks down properly in the body, releasing the drug at the intended rate for optimal absorption. Both capsules and tablets undergo dissolution testing to meet regulatory requirements and ensure consistent drug performance. Other dosage forms, such as powders, lozenges, or extended-release forms, are also subject to dissolution testing, depending on their composition and intended release profiles. Testing for each dosage form ensures that medications deliver therapeutic benefits effectively and safely.
By Dissolution Apparatus
Basket
Paddle
Fillers and syringh
Dissolution Media
Others
In pharmaceutical dissolution testing, various dissolution apparatus are used to simulate in vivo conditions and assess how quickly and completely a drug dissolves. The Basket apparatus is commonly used for testing solid dosage forms like capsules and tablets, where the drug is placed in a rotating mesh basket submerged in a dissolution medium. The Paddle apparatus uses a stirring paddle to agitate the medium, ensuring the drug dissolves evenly and consistently. Fillers and syringes are employed to measure and handle the dissolution medium, ensuring precise volumes and accurate sample collection during testing. Dissolution media, such as buffers or simulated gastric fluids, mimic the environment inside the human body, providing realistic conditions for drug release. Other apparatus and methods include specialized tools for testing different dosage forms or ensuring controlled release in extended-release formulations. Together, these apparatus and techniques provide a standardized way to evaluate drug dissolution and ensure consistent therapeutic performance.
By End User
Pharmaceutical Companies
Contract Research Organizations (CROs)
Academic and Research Institutions
Regulatory Laboratories
In pharmaceutical dissolution testing, various end users rely on the process for ensuring drug quality, efficacy, and compliance. Pharmaceutical companies are the primary users, conducting dissolution tests during drug development, formulation optimization, and quality control to ensure that their products meet regulatory standards for bioavailability and release profiles. Contract Research Organizations (CROs) perform dissolution testing on behalf of pharmaceutical companies, offering specialized expertise and outsourcing services for drug development, testing, and clinical trials. Academic and research institutions utilize dissolution testing for scientific studies, focusing on understanding drug release mechanisms, improving formulations, and contributing to pharmaceutical research. Regulatory laboratories, such as those operated by government agencies like the FDA or EMA, use dissolution testing to verify compliance with regulations, ensuring that drugs released to the market meet safety and efficacy standards. These diverse end users rely on dissolution testing as a key tool in the development, approval, and continuous monitoring of pharmaceutical products.
By Key Players
Intertek Group Plc.
Avivia BV
Almac Group
Agilent Technologies, Inc.
Catalent, Inc.
Thermofisher Scientific Inc.
Cambrex Corp.
Charles River Laboratories
Boston Analytical
Pace Analytical Life Sciences
SOTAX
AMRI
SGS SA
Please ask for sample pages for full companies list
Base Year: 2023
Historical Data: from 2019 to 2023
Forecast Data: from 2024 to 2031
Any special requirements about this report, please let us know and we can provide custom report.
TABLE OF CONTENTS
Market Taxonomy
1. Executive Summary
1.1. Market Overview
1.2. Market Analysis and Recommendations
1.3. RA Analysis and Recommendations
2. Market Introduction
2.1. Market Definition
3. Market Background
3.1. Parent/Associated Market Overview
3.1.1.Pharmaceutical Dissolution Outlook
3.1.2.Pharmaceutical Dissolution Overview
3.2. Effect of Covid-19 Impact
3.3. Macro-Economic Overview
3.3.1. GDP Growth
3.3.2. Retail Industry Growth
3.4. Pricing Analysis
3.5. Challenges related to adoption of Pharmaceutical Dissolution
3.6. Regulations of Pharmaceutical Dissolution
3.7. Forecast Factors: Relevance and Impact
3.8. Market Dynamics
3.8.1. Drivers
3.8.2. Restraints
3.8.3. Opportunity
3.8.4. Trends
3.8.5. SWOT Analysis
4. Market Forecast
4.1. Market Value Projections
4.2. Market Size Projections
4.3. Y-o-Y Projections
4.4. Absolute Opportunity Analysis
5. Global Pharmaceutical Dissolution Value Chain Analysis
5.1.Pharmaceutical Dissolution Value Chain
5.1.1. List of Raw Dissolution Apparatus Suppliers
5.1.2. List of Pharmaceutical Dissolution Manufacturer
5.1.3. List of Segment
6. Global Pharmaceutical Dissolution Analysis by Dosage Form
6.1. Introduction
6.1.1. Market Value Share Analysis By Dosage Form
6.1.2. Y-o-Y Growth Analysis By Dosage Form
6.2. Historical Market Size (USD Mn) Analysis 2018-2022 By Dosage Form
6.3. Market Attractiveness Analysis by Dosage Form
7. GlobalPharmaceutical Dissolution Analysis By Dissolution Apparatus
7.1. Introduction
7.1.1. Market Value Share Analysis By Dissolution Apparatus
7.1.2. Y-o-Y Growth Analysis By Dissolution Apparatus
7.2. Historical Market Size (USD Mn) Analysis 2018-2022 By Dissolution Apparatus
7.3. Market Attractiveness Analysis By Dissolution Apparatus
8. Market Structure Analysis
8.1. Market Analysis by Tier of Companies
8.1.1. By Large, Medium, and Small
8.2. Market Concentration
8.2.1. By Top 5 and by Top 10
8.3. Type ion Capacity Share Analysis
8.3.1. By Large, Medium, and Small
8.3.2. By Top 5 and Top 10
8.4. Dosage Form Roadmap
9. Competition Analysis
9.1. Competition Dashboard
9.2. Company Profiles (15 Companies)
9.2.1.Intertek Group Plc.
9.2.1.1. Overview
9.2.1.2. Type Portfolio
9.2.1.3. Financial Overview
9.2.2. Beckton,
9.2.2.1. Overview
9.2.2.2. Type Portfolio
9.2.2.3. Financial Overview
9.2.3. Almac Group
9.2.3.1. Overview
9.2.3.2. Type Portfolio
9.2.3.3. Financial Overview
9.2.4. Agilent Technologies, Inc.
9.2.4.1. Overview
9.2.4.2. Type Portfolio
9.2.4.3. Financial Overview
9.2.5. Catalent, Inc.
9.2.5.1. Overview
9.2.5.2. Type Portfolio
9.2.5.3. Financial Overview
9.2.6.Thermofisher Scientific Inc.
9.2.6.1. Overview
9.2.6.2. Type Portfolio
9.2.6.3. Financial Overview
9.2.7.Cambrex Corp.
9.2.7.1. Overview
9.2.7.2. Type Portfolio
9.2.7.3. Financial Overview
9.2.8. Charles River Laboratories
9.2.8.1. Overview
9.2.8.2. Type Portfolio
9.2.8.3. Financial Overview
9.2.9. Boston Analytical
9.2.9.1. Overview
9.2.9.2. Type Portfolio
9.2.9.3. Financial Overview
9.2.10.Pace Analytical Life Sciences
9.2.10.1. Overview
9.2.10.2. Type Portfolio
9.2.10.3. Financial Overview
9.2.11.SOTAX
9.2.11.1. Overview
9.2.11.2. Type Portfolio
9.2.11.3. Financial Overview
9.2.12. F. AMRI
9.2.12.1. Overview
9.2.12.2. Type Portfolio
9.2.12.3. Financial Overview
9.2.13. SGS SA
9.2.13.1. Overview
9.2.13.2. Type Portfolio
9.2.13.3. Financial Overview
9.2.14. COMPANY 14
9.2.14.1. Overview
9.2.14.2. Type Portfolio
9.2.14.3. Financial Overview
9.2.15. COMPANY 15
9.2.15.1. Overview
9.2.15.2. Type Portfolio
9.2.15.3. Financial Overview
10. Global Pharmaceutical Dissolution Analysis By Region
10.1. Introduction
10.1.1. Market Value Share Analysis By Region
10.1.2. Y-o-Y Growth Analysis By Region
10.2. Historical Market Size (USD Mn) Analysis 2018-2022 By Region
10.2.1. North America
10.2.2. Middle East and Africa
10.2.3. South America
10.2.4. Asia-Pacific
10.2.5. Others
10.3. Current Market Size (USD Mn) Forecast 2023-2030 By Region
10.3.1. North America
10.3.2. Middle East and Africa
10.3.3. South America
10.3.4. Asia-Pacific
10.3.5. Others
10.4. Market Attractiveness Analysis By Region
11. North America Pharmaceutical Dissolution Analysis
11.1. Introduction
11.2. Historical Market Size (USD Mn) Analysis 2018-2022 By Country
11.2.1. U.S.
11.2.2. Canada
11.2.3. Mexico
11.2.4. Rest of North America
11.3. Current Market Size (USD Mn) Forecast 2023-2030 By Country
11.3.1. U.S.
11.3.2. Canada
11.3.3. Mexico
11.3.4. Rest of North America
11.4. Historical Market Size (USD Mn) Analysis 2018-2022 By Dosage Form
11.5. Current Market Size (USD Mn) Forecast 2023-2030 By Dosage Form
11.6. Historical Market Size (USD Mn) Analysis 2018-2022 By Dissolution Apparatus
11.7. Current Market Size (USD Mn) Forecast 2023-2030 By Dissolution Apparatus
12. South America Pharmaceutical Dissolution Analysis
12.1. Introduction
12.2. Regional Pricing Analysis
12.3. Historical Market Size (USD Mn) Analysis 2018-2022 By Country
12.3.1. Brazil
12.3.2. Argentina
12.3.3. Rest of South America
12.4. Current Market Size (USD Mn) Forecast 2023-2030 By Country
12.4.1. Brazil
12.4.2. Argentina
12.4.3. Rest of South America
12.5. Historical Market Size (USD Mn) Analysis 2018-2022 By Dosage Form
12.6. Current Market Size (USD Mn) Forecast 2023-2030 By Dosage Form
12.7. Historical Market Size (USD Mn) Analysis 2018-2022 By Dissolution Apparatus
12.8. Current Market Size (USD Mn) Forecast 2023-2030 By Dissolution Apparatus
13. Europe Pharmaceutical Dissolution Analysis
13.1. Introduction
13.2. Regional Pricing Analysis
13.3. Historical Market Size (USD Mn) Analysis 2018-2022 By Country
13.3.1. Germany
13.3.2. Italy
13.3.3. France
13.3.4. Spain
13.3.5. U.K.
13.3.6. Rest of Europe
13.4. Current Market Size (USD Mn) Forecast 2023-2030 By Country
13.4.1. Germany
13.4.2. Italy
13.4.3. France
13.4.4. Spain
13.4.5. U.K.
13.4.6. Rest of Europe
13.5. Historical Market Size (USD Mn) Analysis 2018-2022 By Dosage Form
13.6. Current Market Size (USD Mn) Forecast 2023-2030 By Dosage Form
13.7. Historical Market Size (USD Mn) Analysis 2018-2022 By Dissolution Apparatus
13.8. Current Market Size (USD Mn) Forecast 2023-2030 By Dissolution Apparatus
14. Middle East and Africa Pharmaceutical Dissolution Analysis
14.1. Introduction
14.2. Regional Pricing Analysis
14.3. Historical Market Size (USD Mn) Analysis 2018-2022 By Country
14.3.1. Saudi Arabia
14.3.2. U.A.E.
14.3.3. South Africa
14.3.4. Turkey
14.3.5. Rest of Middle East and Africa
14.4. Current Market Size (USD Mn) Forecast 2023-2030 By Country
14.4.1. Saudi Arabia
14.4.2. U.A.E.
14.4.3. South Africa
14.4.4. Turkey
14.4.5. Rest of Middle East and Africa
15. Asia-Pacific Pharmaceutical Dissolution Analysis
15.1. Introduction
15.2. Regional Pricing Analysis
15.3. Historical Market Size (USD Mn) Analysis 2018-2022 By Country
15.3.1. China
15.3.2. India
15.3.3. Japan
15.3.4. South Korea
15.3.5. Singapore
15.3.6. Australia and New Zealand
15.3.7. Rest of Asia-Pacific
15.4. Current Market Size (USD Mn) Forecast 2023-2030 By Country
15.4.1. China
15.4.2. India
15.4.3. Japan
15.4.4. South Korea
15.4.5. Singapore
15.4.6. Australia and New Zealand
15.4.7. Rest of Asia-Pacific
i. Research Methodology
ii. Assumptions & Acronyms
LIST OF FIGURES
Figure 01: Global Pharmaceutical Dissolution, BPS Analysis,By Dosage Form, 2018(H), 2023(E) & 2030(F)
Figure 02: Global Pharmaceutical Dissolution, Y-O-Y Growth,By Dosage Form, 2020(A) - 2030(F)
Figure 03: Global Pharmaceutical Dissolution Attractiveness Analysis,By Dosage Form (2020)
Figure 04: Global Pharmaceutical Dissolution, BPS Analysis, By Dissolution Apparatus, 2018(H), 2023(E) & 2030(F)
Figure 05: Global Pharmaceutical Dissolution, Y-O-Y Growth, By Dissolution Apparatus, 2018(H) - 2030(F)
Figure 06: Global Pharmaceutical Dissolution Attractiveness Analysis, By Dissolution Apparatus
Figure 07: Global Pharmaceutical Dissolution, Value Analysis,By Dosage Form, 2018(H)-2030(F)
Figure 08: Global Pharmaceutical Dissolution, Value Analysis, by Dissolution Apparatus , 2018(H)-2030(F)
Figure 09: Global Pharmaceutical Dissolution, BPS Analysis, by Region, 2018(H), 2023(E) & 2030(F)
Figure 10: Global Pharmaceutical Dissolution, Y-O-Y Growth, by Region, 2018(H) - 2030(F)
Figure 11: Global Pharmaceutical Dissolution Attractiveness Analysis, by Region
Figure 12: North America Pharmaceutical Dissolution Value (USD Mn Forecast, 2018 – 2022
Figure 13: North America Pharmaceutical Dissolution Value (USD Mn Forecast, 2023 – 2030
Figure 14: South America Pharmaceutical Dissolution Value (USD Mn) Forecast, 2018 – 2022
Figure 15: South America Pharmaceutical Dissolution Value (USD Mn) Forecast, 2023 – 2030
Figure 16: Europe Pharmaceutical Dissolution Value (USD Mn) Forecast, 2018 – 2022
Figure 17: Europe Pharmaceutical Dissolution Value (USD Mn) Forecast, 2023 – 2030
Figure 18: Middle East and Africa Pharmaceutical Dissolution Value (USD Mn) Forecast, 2018 – 2022
LIST OF TABLES
Table 01: Global Pharmaceutical Dissolution Value (USD Mn) Forecast, By Dosage Form, 2018(H) – 2030(F)
Table 02: Global Pharmaceutical Dissolution Value (USD Mn) Forecast, By Dissolution Apparatus, 2018(H) – 2030(F)
Table 03: Global Pharmaceutical Dissolution Value (USD Mn) Forecast, By Country, 2018(H) – 2030(F)
Table 04: North America Pharmaceutical Dissolution Value (USD Mn) Forecast, by Country, 2018(H) – 2030(F)
Table 05: North America Pharmaceutical Dissolution Value (USD Mn) Forecast,By Dosage Form, 2018(H) – 2030(F)
Table 06: North America Pharmaceutical Dissolution Value (USD Mn) Forecast, By Dissolution Apparatus, 2018(H) – 2030(F)
Table 07: South America Pharmaceutical Dissolution Value (USD Mn) Forecast, By Country, 2018(H) – 2030(F)
Table 08: South America Pharmaceutical Dissolution Value (USD Mn) Forecast,By Dosage Form, 2018(H) – 2030(F)
Table 09: South America Pharmaceutical Dissolution Value (USD Mn) Forecast, By Dissolution Apparatus, 2018(H) – 2030(F)
Table 10: Europe Pharmaceutical Dissolution Value (USD Mn) and Forecast, by Country, 2018(H) – 2030(F)
Table 11: Europe Pharmaceutical Dissolution Value (USD Mn) Forecast, By Dosage Form, 2018(H) – 2030(F)
Table 12: Europe Pharmaceutical Dissolution Value (USD Mn) Forecast, By Dissolution Apparatus EndUser, 2018(H) – 2030(F)
Table 13: Middle East and Africa Pharmaceutical Dissolution Value (USD Mn) Forecast, By Country, 2018(H) – 2030(F)
Table 14: Middle East and Africa Pharmaceutical Dissolution Value (USD Mn) Forecast, By Dosage Form, 2018(H) – 2030(F)
Table 15: Middle East and Africa Pharmaceutical Dissolution Value (USD Mn) Forecast, By Dissolution Apparatus, 2018(H) – 2030(F)
Table 16: Asia-Pacific Pharmaceutical Dissolution Value (USD Mn) Forecast, by Country, 2018(H) – 2030(F)
Table 17: Asia-Pacific Pharmaceutical Dissolution Value (USD Mn) Forecast, By Dosage Form, 2018(H) – 2030(F)
Table 18: Asia-Pacific Pharmaceutical Dissolution Value (USD Mn) Forecast, By Dissolution Apparatus, 2018(H) – 2030(F)
Direct Purchase
Your perfect start with Stats And ResearchWant to customize this report?
This report can be customized according to your requirements. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time.
Avail PDF Sample Reports
You may also be lnterested in..
Stats And Research ™ Copyright © 2024 .